首页 > 市场调查报告书 > 医疗设备

生物材料

市场调查报告书

商品编码

1533651

生医材料市场规模、份额和成长分析：按类型、应用和地区划分 - 产业预测，2024-2031 年

Biomaterials Market Size, Share, Growth Analysis, By Type (Natural Biomaterial, Metallic Biomaterial), Application (Neurology, Cardiology), By Region - Industry Forecast 2024-2031

出版日期: 2024年08月05日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年生医材料市场规模将为1,354亿美元，从2023年的1,559亿美元成长到2031年的4,381亿美元，预计在预测期内（2024-2031年）复合年增长率为15.4%。

生医材料是人造材料，无论是合成的还是天然的，用于医疗技术中以改善受损组织和器官的功能。它们透过增强、替代和支持受损的生物功能，在医疗保健中发挥重要作用。这些材料可以源自金属、陶瓷、塑胶、聚合物，甚至是活细胞和组织。常见应用包括医疗植入，如心臟瓣膜、支架、移植物、人工关节、韧带、肌腱和人工植牙系统。生医材料市场成长的驱动力是整形外科和创伤治疗的使用增加、心血管、神经和整形外科疾病盛行率的上升、老年人口的增加、对植入设备的需求增加以及政府和学术机构的创新资金增加。

市场概况
金属生医材料
- 不銹钢
- 钛/钛合金
- 钴铬合金
- 银
- 金子
- 镁
- 其他金属生医材料
高分子生医材料
- 聚甲基丙烯酸甲酯
- 聚乙烯
- 聚酯纤维
- 聚氯乙烯
- 硅橡胶
- 尼龙
- 聚醚醚酮
- 其他高分子生医材料
陶瓷生医材料
- 磷酸钙
- 氧化锆
- 氧化铝
- 硫酸钙
- 碳
- 玻璃
天然生医材料
- 玻尿酸
- 胶原蛋白
- 纤维蛋白
- 纤维素
- 甲壳质
- 藻酸盐
- 明胶
- 几丁聚醣
- 丝绸
- 其他天然生医材料

生医材料市场：依应用分类

市场概况
整形外科
- 关节重建手术
- 关节重建置换术
- 髋置换术
- 肩关节关节重建
- 其他关节重建手术
- 生物可吸收组织固定
- 缝合锚钉
- 网筛
- 超音波振动
- 干涉螺丝
- 半月软骨修补术
- 网
- 脊椎手术
- 脊椎融合手术
- 微创融合术
- 运动保持/动态稳定化
- 椎弓根棒系统
- 棘突间活动式支架
- 人工椎间盘
- 骨折固定
- 骨板
- 拧紧
- 别针
- 桿
- 金属丝
- 生物性骨材
心血管
- 导管
- 支架
- 植入
- 心律调节器
- 感应器
- 心臟瓣膜
- 血管移植
- 导管导引线
- 其他心血管产品
眼科
- 隐形眼镜
- 人工水晶体
- 眼组织的功能性替代
- 人工角膜
- 其他眼科产品
牙科
- 人工植牙
- 牙科骨移植/人工骨骼替代物
- 牙膜
- 组织再生材料
整形外科
- 软组织填充剂
- 颅颜外科产品
- 脸部皱纹治疗设备
- 生物工程皮肤
- 週边神经修復装置
- 去细胞真皮基质
- 伤口癒合
- 伤口缝合装置
- 缝合
- 订书钉
- 手术止血钳
- 内部组织密封胶
- 防沾黏屏障
- 疝气网
- 皮肤替代品
组织工程
- 扫描摺迭
- 奈米材料
- 无机奈米粒子
神经系统/中枢神经系统
- 调车系统
- 皮质神经假体
- 水凝胶支架
- 神经干细胞封装产品
泌尿道
- 导尿管
- 尿道支架
- 其他尿製品
其他用途
- 药物输送系统
- 胃肠道
- 减重手术

生医材料市场规模：按地区划分

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

BASF SE（Germany）
Covestro AG（Germany）
Celanese Corporation（Germany）
Carpenter Technology（US）
Olympus Terumo Biomaterials Corporation（Japan）
Evonik Industries AG（Germany）
Xylos Corporation（US）
Victrex Plc（UK）
Mitsubishi Chemical Holdings Corporation（Japan）
GELITA AG（Germany）
Corbion（Netherlands）
Solvay SA（US）
AB Specialty Silicones（US）
CoorsTek（US）
CeramTec GmbH（Germany）
Royal DSM NV（Netherlands）
The Lubrizol Corporation（US）
Berkeley Advanced Biomaterials（US）
Zeus Industrial Products, Inc.（US）
Noble Biomaterials, Inc.（US）
Dimension Inx（US）
Artoss, Inc.（US）
RDI Group（US）
Riton Biomaterial Co., Ltd.（China）
Cam Bioceramics（Netherlands）

简介目录

Product Code: SQMIG35H2027

Biomaterials Market size was valued at USD 135.4 billion in 2022 and is poised to grow from USD 155.9 billion in 2023 to USD 438.1 billion by 2031, growing at a CAGR of 15.4% in the forecast period (2024-2031).

Biomaterials, whether synthetic or natural, are engineered materials used in medical technology to improve the function of damaged tissues and organs. They play a crucial role in healthcare by helping to augment, replace, or support impaired biological functions. These materials can be derived from metals, ceramics, plastics, polymers, or even living cells and tissues. Common applications include medical implants like heart valves, stents, grafts, artificial joints, ligaments, tendons, and dental implants, as well as sutures, clips, and drug delivery systems that aid in tissue repair. The growth of the biomaterials market is driven by several factors: increasing use in plastic surgery and wound healing, rising incidences of cardiovascular, neurological, and orthopedic conditions, a growing elderly population, higher demand for implantable devices, and increased funding from governments and academic institutions for the development of innovative biomaterials.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biomaterials market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biomaterials Market Segmental Analysis

The global biomaterials market is segmented based on type, application, and region. Based on the type, the market is segmented into natural biomaterial, metallic biomaterial, ceramic biomaterial, and polymeric biomaterial. Based on the application, the market is segmented as neurology, cardiology, orthopedics, ophthalmology, wound care, dental, plastic surgery, and other applications. Based on region, the market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Biomaterials Market

A major driver of growth in the biomaterials industry is the increased funding and grants provided by government agencies and universities for the development of innovative biomaterials. In recent years, the demand and application of biomaterials have significantly risen globally. To support this trend, numerous government bodies and institutions have offered financial assistance, including investments and grants, to foster research and development in this field. For instance, the National Science Foundation awarded Drexel University $200,000 to investigate how biomaterial-mediated control of macrophage behavior impacts biomaterial vascularization. Such funding and research initiatives are expected to accelerate the development of new biomaterials, presenting substantial growth opportunities for the market.

Restraints in the Global Biomaterials Market

A significant challenge to the growth of the biomaterials industry is the stringent clinical and regulatory processes that govern their approval. Biomaterials, particularly those used in implantable medical devices, are subject to rigorous safety and efficacy requirements before they can be marketed. In the United States, the FDA imposes strict standards for these approvals. Devices such as implantable pacemakers, stents, and cardiac valves are classified as Class III by the FDA, which signifies the highest level of risk. Consequently, these devices must undergo the premarket approval (PMA) process, which is the most stringent device marketing application procedure. These rigorous regulations can slow down the market's growth by extending development timelines and increasing costs.

Market Trends of the Global Biomaterials Market

A prominent trend in the global biomaterials market is the growing demand for biomaterials in plastic surgery and wound healing applications. As the population increases and the costs associated with treating damaged or diseased organs rise, implantable devices are increasingly favored for their proven clinical efficacy. These devices are used as scaffolds for restoring both soft and hard tissue deformities, offering significant benefits in wound healing. They promote tissue growth, maintain volume and shape, and accelerate healing times. Major players in the industry are expanding their product offerings for these applications through strategic partnerships and acquisitions. For instance, Advanced Medical Solutions (AMS), a company specializing in surgical and wound care, acquired Biomatlante, a firm focused on surgical biomaterial technologies.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Trade Analysis
Customer & Buying Criteria Analysis
Ecosystem of the Market
Patent Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Market Attractive Index
Degree of Competition

Biomaterials Market by Type

Market Overview
Metallic Biomaterials
- Stainless steel
- Titanium & titanium alloys
- Cobalt-chrome alloys
- Silver
- Gold
- Magnesium
- Other metallic biomaterials
Polymeric Biomaterials
- Polymethylmethacrylate
- Polyethylene
- Polyester
- Polyvinylchloride
- Silicone rubber
- Nylon
- Polyetherether ketone
- Other polymeric biomaterials
Ceramic Biomaterials
- Calcium phosphate
- Zirconia
- Aluminum oxide
- Calcium sulfate
- Carbon
- Glass
Natural Biomaterials
- Hyaluronic acid
- Collagen
- Fibrin
- Cellulose
- Chitin
- Alginates
- Gelatin
- Chitosan
- Silk
- Other natural biomaterials

Biomaterials Market by Application

Market Overview
Orthopedic
- Joint Replacement
- Knee replacement
- Hip replacement
- Shoulder replacement
- Other joint replacement procedures
- Bioresorbable Tissue Fixation
- Suture anchors
- Mesh Screens
- Ultrasonic Vibrations
- Interference screws
- Meniscal repair tacks
- Meshes
- Spine Surgery
- Spinal fusion
- Minimally invasive fusion
- Motion preservation & dynamic stabilization
- Pedicle-based rod systems
- Interspinous spacers
- Artificial discs
- Fracture Fixation
- Bone plates
- Screws
- Pins
- Rods
- Wires
- Orthobiologics
Cardiovascular
- Catheters
- Stents
- Implan
- Pacemakers
- Sensors
- Heart valves
- Vascular grafts
- Guidewires
- Other cardiovascular products
Ophthalmology
- Contact lenses
- Intraocular lenses
- Functional replacement of ocular tissue
- Synthetic corneas
- Other ophthalmology products
Dental
- Dental implants
- Dental bone grafts & substitutes
- Dental membranes
- Tissue regeneration materials
Plastic Surgery
- Soft tissue fillers
- Craniofacial surgery products
- Facial wrinkle treatment devices
- Bioengineered skins
- Peripheral nerve repair devices
- Acellular dermal matrices
- Wound healing
- Wound closure devices
- Sutures
- Staples
- Surgical Hemostats
- Internal tissue sealants
- Adhesion barriers
- Hernia meshes
- Skin substitutes
Tissue Engineering
- Scaffolds
- Nanomaterials
- Inorganic nanoparticles
Neurological/ Central Nervous System
- Shunting systems
- Cortical neural prosthetics
- Hydrogel scaffolds
- Neural stem cell encapsulation products
Urinary
- Urinary catheters
- Urethral stents
- Other urinary products
Other Applications
- Drug delivery systems
- Gastrointestinal
- Bariatric surgery

Biomaterials Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

BASF SE (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Covestro AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Celanese Corporation (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Carpenter Technology (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Terumo Biomaterials Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Evonik Industries AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Xylos Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Victrex Plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mitsubishi Chemical Holdings Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GELITA AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Corbion (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Solvay SA (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AB Specialty Silicones (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CoorsTek (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CeramTec GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Royal DSM NV (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
The Lubrizol Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Berkeley Advanced Biomaterials (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zeus Industrial Products, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Noble Biomaterials, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dimension Inx (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Artoss, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RDI Group (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Riton Biomaterial Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cam Bioceramics (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments